Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Staar Surgical Company (STAA)

Staar Surgical Company (STAA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,233,602
  • Shares Outstanding, K 49,742
  • Annual Sales, $ 313,900 K
  • Annual Income, $ -20,210 K
  • EBIT $ -97 M
  • EBITDA $ -91 M
  • 60-Month Beta 1.01
  • Price/Sales 3.73
  • Price/Cash Flow N/A
  • Price/Book 3.29

Options Overview Details

View History
  • Implied Volatility 113.78% (+8.09%)
  • Historical Volatility 56.90%
  • IV Percentile 99%
  • IV Rank 83.13%
  • IV High 135.13% on 04/16/25
  • IV Low 8.65% on 08/12/25
  • Expected Move (DTE 1) 3.57 (13.79%)
  • Put/Call Vol Ratio 7.03
  • Today's Volume 2,247
  • Volume Avg (30-Day) 2,016
  • Put/Call OI Ratio 4.86
  • Today's Open Interest 60,419
  • Open Int (30-Day) 47,831
  • Expected Range 22.32 to 29.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate -0.04
  • Prior Year -0.59
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.03 +12.42%
on 12/12/25
28.40 -8.84%
on 11/24/25
-0.61 (-2.30%)
since 11/17/25
3-Month
23.03 +12.42%
on 12/12/25
28.40 -8.84%
on 11/24/25
-1.27 (-4.68%)
since 09/17/25
52-Week
13.50 +91.78%
on 02/12/25
30.81 -15.97%
on 08/13/25
+0.45 (+1.77%)
since 12/17/24

Most Recent Stories

More News
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal

STAA : 25.89 (+4.40%)
ALC : 79.26 (+0.30%)
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

Expresses Confidence in STAAR’s Future and the Opportunity for Significant Value Creation Believes STAAR is Worth at Least $50 Per Share If the Company...

STAA : 25.89 (+4.40%)
ALC : 79.26 (+0.30%)
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

Broadwood Has Consistently Misled STAAR Stockholders About Takeover Interest in STAAR In Order to Derail the Alcon Merger STAAR Urges Stockholders to Vote “FOR” the...

STAA : 25.89 (+4.40%)
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory

Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”)...

STAA : 25.89 (+4.40%)
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Increased Alcon Merger Price of $30.75 per Share is an Attractive Outcome for STAAR Stockholders

STAA : 25.89 (+4.40%)
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

ISS Says It Would Not Be “Unreasonable for a Shareholder to Remain Opposed” to the Deal Broadwood Encourages Shareholders to Follow the...

STAA : 25.89 (+4.40%)
ALC : 79.26 (+0.30%)
Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

STAAR Urges Stockholders to Vote “FOR” Alcon Merger on the WHITE Proxy Card TODAY

STAA : 25.89 (+4.40%)
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

Contends STAAR’s Process Was Ineffective in Establishing Competitive Auction and Securing Maximum Value for Shareholders Argues Board’s Procedural...

STAA : 25.89 (+4.40%)
ALC : 79.26 (+0.30%)
Why STAAR Surgical (STAA) Stock Is Up Today

Why STAAR Surgical (STAA) Stock Is Up Today

STAA : 25.89 (+4.40%)
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

Activist Investors Have Twisted Facts Regarding STAAR’s Engagement with a Potentially Interested Party During Go-Shop Process The Potentially Interested Party Reached...

STAA : 25.89 (+4.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

See More

Key Turning Points

3rd Resistance Point 28.14
2nd Resistance Point 27.16
1st Resistance Point 26.52
Last Price 25.89
1st Support Level 24.91
2nd Support Level 23.93
3rd Support Level 23.30

See More

52-Week High 30.81
Last Price 25.89
Fibonacci 61.8% 24.20
Fibonacci 50% 22.15
Fibonacci 38.2% 20.11
52-Week Low 13.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar